FDA Cosmetic, Food, and Medical Device Data Elements in ACE

The first paragraph, which uses PAS formula to grab the reader's attention (max 30 words). Navigating the maze of FDA regulations¹ can be overwhelming. Importers face significant risks of delays and holds if they don’t know the right data elements required in ACE.

FDA data elements in ACE are the product and compliance details submitted electronically with a customs entry so FDA can determine admissibility of FDA-regulated goods. ACE/ITDS² acts as a “single window” connecting CBP and FDA, allowing FDA to screen entries using identifiers like product code³, intended use⁴, manufacturer data⁵, and required compliance flags under 21 CFR §1.72⁶.

Understanding FDA data elements in ACE is crucial for importers. If you submit incorrect information, it can lead to holds, delays, and unnecessary complications. The CBP Single Window uses entry data to determine whether goods are admissible. This means that the details you provide must be accurate and complete.

What FDA “data elements in ACE” mean for importers?

The first paragraph, which uses the PAS strategy to grab the reader's attention (max 30 words). Importers often overlook the importance of accurate data elements. This oversight can lead to costly delays and additional scrutiny by the FDA during the import process.

FDA data elements in ACE are essential for ensuring compliance with regulations. Submitting the correct information helps facilitate the FDA's admissibility screening process and minimizes the risk of holds or delays on shipments.

Understanding how ACE/ITDS² functions as a PGA message set is essential for importers. This system connects the CBP with the FDA, allowing for efficient data exchange. Importers are responsible for the accuracy of the submitted data, even if a customs broker files the entry.

Here’s a simplified workflow of the process:

1. Importer collects product and compliance data
2. Broker transmits the FDA PGA message set in ACE
3. FDA conducts admissibility screening
4. Shipment may proceed, hold, undergo examination, or face refusal recommendation
5. CBP releases the shipment once requirements are satisfied

This framework ensures that both the FDA and importers can effectively manage compliance and reduce the likelihood of potential delays.

Core ACE filing data required under 21 CFR §1.72⁶

The first paragraph, which uses the PAS strategy to grab the reader's attention (max 30 words). Missing key data elements can lead to unnecessary delays. Understanding the requirements under 21 CFR §1.72⁶ is vital for smooth import operations.

Under 21 CFR §1.72⁶, ACE filers must submit specific FDA data elements for regulated products, including country of production, complete FDA product code³, full intended use⁴ code, and importer contact details, plus additional information depending on the commodity type. Missing or inconsistent values commonly trigger FDA holds, requests for information, or admissibility delays.

The core elements required across all categories include:

• FDA Country of Production⁷: Essential for determining the source of the product.
• Complete FDA Product Code⁸: Identifies the category of the product.
• Full Intended Use Code (IUC)⁹: Helps the FDA assess the proper regulatory pathway.
• Importer Contact Details¹⁰: Provides a point of contact for any issues.
• Entity Identifiers for Manufacturer/Shipper¹¹: Ensures traceability.
• AofC Where Required: Dependent on the product type.

Below is a checklist of the core FDA ACE data elements:

Data Element	What It Means	Who Provides	Where to Get It	Common Error	Risk
FDA Country of Production7	Country where the product was manufactured	Importer/Supplier	Manufacturer documents	Incorrect country listed	Hold
Complete FDA Product Code8	Code that defines the product category	Importer	FDA's product database	Missing product code3	Admissibility delay
Full Intended Use Code (IUC)9	Code that specifies the product's intended use4	Importer	Product labeling or FDA guidelines	Incorrect intended use4 specified	Hold
Importer Contact	Contact person for any inquiries	Importer	Internal records	Missing contact information	Communication delay
Entity Identifiers	Identifiers for the manufacturer or shipper	Importer	Supplier documentation	Mismatched names/addresses	Hold
Affirmation of Compliance (AofC)12	Certification that product meets regulations	Importer	Regulatory documents	Missing AofC when required	Admissibility delay

This checklist is vital for importers to ensure compliance with FDA regulations¹ and avoid potential delays in their shipments.

Food imports: the most critical FDA data elements that drive holds

The first paragraph, which uses the PAS strategy to grab the reader's attention (max 30 words). Food imports are often scrutinized by the FDA. Understanding the critical data elements can help avoid headaches and ensure compliance.

Food shipments are high-risk for FDA holds because admissibility depends on complete and consistent identifiers—FDA product code³, intended use⁴, manufacturer/shipper details, and Prior Notice¹³-linked compliance data. In ACE, incorrect product coding or missing compliance information can trigger “May Proceed” delays, requests for documentation, or holds until the importer clarifies product details and facility information.

For food imports, the following data elements are critical:

• Prior Notice¹³: A requirement that must be submitted before the food product arrives in the U.S. It provides the FDA with advance notice of imports.
• FDA Product Codes: These codes categorize the food items and must be accurate.
• Affirmations of Compliance (AofC): These are needed to ensure the food complies with all applicable regulations.
• Facility Identifiers¹⁴: Registration details are crucial for tracking the source.

To help you avoid FDA holds, here’s a checklist for food data elements within ACE:

Field	Required?	Example	Source Document	Hold Trigger If Wrong
FDA Product Code	Always	123456	Product labeling	Incorrect product code3
Prior Notice13	Always	12345-67890	Shipping documents	Missing prior notice
Facility Identifier	Sometimes	ABC Food Co., Facility ID	FDA registration	Unregistered facility
AofC	Sometimes	Affirmation form	Compliance documents	Missing AofC when required

This table highlights the crucial components required for food imports under FDA regulations¹.

Cosmetics imports: ACE data elements and today’s compliance drivers

The first paragraph, which uses the PAS strategy to grab the reader's attention (max 30 words). Cosmetics imports face unique challenges. Ensuring that all necessary data elements are submitted accurately is key to avoiding holds.

Cosmetics require accurate ACE data because FDA screening relies heavily on product code³ and intended use⁴ to assess whether the product is regulated as a cosmetic, drug, or both. Importers frequently trigger holds by using incorrect product code³s, vague descriptions, or inconsistent manufacturer data⁵. A broker-ready product dataset significantly improves admissibility outcomes and reduces delays.

When it comes to cosmetics, understanding the data elements necessary for compliance is crucial.

Key factors include:

• Product Coding: Accurate product code³s are essential for proper classification.
• Intended Use: Clearly defined intended use⁴ helps the FDA determine regulatory requirements.
• MoCRA Compliance¹⁵: Recent regulations have increased the scrutiny on cosmetics imports, making compliance even more necessary.

Here’s a table of essential cosmetic data elements for importers:

Field	Example	Common Mistake	Risk Outcome	Prevention Control
FDA Product Code	12345	Incorrect product code3	Hold	Validate product code3
Intended Use	Cosmetic	Vague descriptions	Admissibility delays	Specify intended use4 clearly
AofC	Affirmation form	Missing AofC	Delays in customs	Ensure AofC is included
Packaging Claims	"Moisturizing Cream"	Misleading claims	Regulatory action	Follow labeling guidelines

These elements help streamline the import process for cosmetics and ensure compliance with FDA regulations¹.

Medical devices imports: ACE data elements that cause the most delays

The first paragraph, which uses the PAS strategy to grab the reader's attention (max 30 words). Medical device imports can be particularly complex. The right data elements can make a significant difference in the efficiency of the import process.

Medical device imports frequently face FDA review because admissibility depends on accurate device identification and compliant manufacturer/shipper information in ACE. Incorrect product coding, unclear intended use⁴, and missing compliance data often trigger holds. Importers reduce delays by maintaining a structured device dataset, aligning invoice descriptions to FDA product code³s, and validating manufacturer information before shipment.

For medical devices, it is crucial to provide accurate data elements to prevent delays.

The necessary factors include:

• Device Identification¹⁶: Clear identification of the medical device is essential.
• Product Code/IUC: Accurate codes ensure that the FDA can assess the product correctly.
• Manufacturer Consistency: The information provided must match across all documents.

Here’s a checklist of medical device data elements:

Field	What It Is	Source	Example	Delay Trigger
Device Product Code	FDA classification code	FDA product database	98765	Missing product code3
Intended Use Code (IUC)	Product's purpose	Manufacturer documentation	Surgical use	Incorrect intended use4
Manufacturer/Entity Data	Info about the manufacturer	Regulatory documents	XYZ Medical Devices Co.	Inconsistent data
Registration Signals17	Compliance documentation	FDA registration	Registered device ID	Missing registration info

This checklist can assist importers in navigating the complex landscape of medical device regulations and ensure a smoother import process.

Importer SOP to avoid FDA holds in ACE

The first paragraph, which uses the PAS strategy to grab the reader's attention (max 30 words). Implementing a standard operating procedure¹⁸ can greatly reduce FDA holds. A proactive approach ensures that all necessary data elements are collected upfront.

The most reliable way to reduce FDA holds is to control data upstream. Importers should require suppliers to provide standardized product identifiers, manufacturer details, and compliance attributes, then validate these fields before the shipment reaches the port. A broker-ready dataset¹⁹ improves ACE transmission accuracy, speeds FDA admissibility review²⁰, and reduces costly exam-related delays.

To create a robust SOP, consider the following steps:

1. Supplier Data Collection: Gather all necessary product identifiers, compliance data, and manufacturer details upfront.
2. Broker-Ready Templates: Use templates to ensure consistency in the data submitted.
3. Pre-Check Workflow: Validate data before shipment to minimize errors.
4. Exam Contingency Plan: Prepare for the possibility of holds by having protocols in place.

The workflow diagram to streamline the process is as follows:

• Supplier product master data
• Importer compliance screening + product code³/IUC mapping
• Broker-ready ACE template created
• Shipment booked + documents aligned
• Entry filed with FDA PGA message set in ACE
• FDA admissibility review²⁰
• May Proceed or Hold
• Hold response SOP (documents + corrective data)
• Release + recordkeeping

This structured approach can help importers avoid FDA holds and ensure a smoother import process.

Conclusion

Navigating FDA data requirements in ACE is crucial. Accurate data submission helps avoid holds, delays, and costly mistakes.

---